Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- Maastricht University (UM)
- Sanquin Blood Supply Foundation (Sanquin)
- Duke University
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- Harvard University
- Institute of Neuroscience and physiology, Sahlgrenska Academy, university of Gothenburg
- National Institute of Materials Physics
- National Research Council Canada
- The University of Manchester
- Umeå University
- University of Birmingham
- University of Copenhagen
- University of Oslo
- University of Texas at El Paso
- University of Würzburg - Rudolf Virchow Center for Integrative and Translational Bioimaging
- 5 more »
- « less
-
Field
-
employing novel antibody formats that can arrest bleeding. Currently, no specific treatment of bleeding linked to trauma and/or surgery is available; the majority of patients are treated by administration
-
Landsteiner Laboratory). This project focuses on developing coagulation factor mimetics employing novel antibody formats that can arrest bleeding. Currently, no specific treatment of bleeding linked to trauma
-
, antibody-producing cells that play an essential role in the immune response. Multiple myeloma accounts for approximately 10% of all blood cancers, and despite significant advances in treatment, it remains
-
Translationnelle (Saclay, France). Together, we are developing innovative imaging workflows that provide unprecedented insight into the biodistribution, efficacy and safety of Antibody-Drug Conjugates (ADCs)—one
-
University of Würzburg - Rudolf Virchow Center for Integrative and Translational Bioimaging | Oettingen in Bayern, Bayern | Germany | 3 months ago
proteins using a wide range of imaging methods. The Rudolf Virchow Center is looking for a PhD student (f/m/d) (Bioimaging / Biophysics) in the field of whole organ fluorescence imaging Antibodies
-
Institute of Neuroscience and physiology, Sahlgrenska Academy, university of Gothenburg | Sweden | 4 days ago
. Project description: Alzheimer's disease (AD) places an enormous burden on patients, families and society. Newly approved anti-amyloid antibodies are most effective when given early, ideally before symptoms
-
and virtual health technologies expertise and facilities. Additionally, MDRC’s is located in Royalmount site at Montreal which includes antibody and molecular technologies expertise and facilities. MDRC
-
project „Portable platform for the in vitro analysis of a large number of antigens, antibodies and genetic material sequences”. 1. Available positions Two positions of research assistant (PhD student) in
-
of the manufacture of recombinant medicines (antibodies, domain-engineered multi-specifics). This work is part of our research portfolio directed towards engineering improvements into CHO cells as a chassis biofactory
-
and their antibodies contribute to chronic (low grade) inflammation and the development of cardiometabolic diseases. By studying complement activation and is association with (sub)clinical phenotypes